The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson’s Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On حسب Pekka T. Männistö, Tapani Keränen, Kari J. Reinikainen, Anna Hanttu, Piero Pollesello

احصل على النص الكامل